Autolus Therapeutics (AUTL) Leases: 2019-2025
Historic Leases for Autolus Therapeutics (AUTL) over the last 5 years, with Sep 2025 value amounting to $56.6 million.
- Autolus Therapeutics' Leases fell 6.41% to $56.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.6 million, marking a year-over-year decrease of 6.41%. This contributed to the annual value of $55.5 million for FY2024, which is 8.71% down from last year.
- Autolus Therapeutics' Leases amounted to $56.6 million in Q3 2025, which was down 3.40% from $58.6 million recorded in Q2 2025.
- Autolus Therapeutics' 5-year Leases high stood at $60.8 million for Q4 2023, and its period low was -$902,000 during Q1 2021.
- In the last 3 years, Autolus Therapeutics' Leases had a median value of $57.7 million in 2024 and averaged $55.1 million.
- In the last 5 years, Autolus Therapeutics' Leases crashed by 103.80% in 2021 and then skyrocketed by 2,025.28% in 2022.
- Over the past 5 years, Autolus Therapeutics' Leases (Quarterly) stood at $18.8 million in 2021, then rose by 23.62% to $23.2 million in 2022, then soared by 161.92% to $60.8 million in 2023, then fell by 8.71% to $55.5 million in 2024, then dropped by 6.41% to $56.6 million in 2025.
- Its Leases stands at $56.6 million for Q3 2025, versus $58.6 million for Q2 2025 and $56.2 million for Q1 2025.